Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis
June 29, 2018 07:00 ET | Dermira, Inc.
Qbrexza is the first FDA-approved, once-daily, topical prescription treatment indicated for people with primary axillary hyperhidrosis, also known as excessive underarm sweating The chronic, medical...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 08, 2018 16:01 ET | Dermira, Inc.
MENLO PARK, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Present at Jefferies 2018 Global Healthcare Conference
May 30, 2018 16:01 ET | Dermira, Inc.
MENLO PARK, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Host Analyst & Investor Day on May 24, 2018
May 14, 2018 08:30 ET | Dermira, Inc.
MENLO PARK, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2018 16:03 ET | Dermira, Inc.
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports First Quarter 2018 Financial Results and Provides Corporate Update 
May 03, 2018 16:02 ET | Dermira, Inc.
FDA decision on glycopyrronium tosylate New Drug Application expected by June 30, 2018Lebrikizumab Phase 2b study enrolling patients, data expected in first half of 2019 MENLO PARK, Calif., May 03,...
Dermira and Cameran Eubanks Team Up to Raise Awareness of Excessive Sweating for the 15 Million People Living with the Condition in the U.S.
May 02, 2018 08:00 ET | Dermira, Inc.
MENLO PARK, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Reality television personality Cameran Eubanks and Dermira, Inc. (NASDAQ:DERM) announced today that they are collaborating on a new educational...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira to Present at Deutsche Bank 43rd Annual Healthcare Conference
May 01, 2018 16:02 ET | Dermira, Inc.
MENLO PARK, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...
Dermira_Logo_RGB_R4V2_M01.jpg
Christopher Horan Joins Dermira as Chief Technical Operations Officer
April 19, 2018 16:04 ET | Dermira, Inc.
Previously served as Senior Vice President, Global Product and Supply Chain Management at Genentech, Inc. (Roche)Brings more than 25 years of biopharma operations experience to Dermira    MENLO...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 11, 2018 16:05 ET | Dermira, Inc.
MENLO PARK, Calif., April 11, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering...